Plus Therapeutics, Inc.
PSTVCIK 0001095981 · last filing Jul 1, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
24,034 bought / 0 sold
net +24,034 sh
- buys
- 11
- sells
- 0
- insiders active
- 7
Filing tape
Filed Wed, Jul 1, 2026
- +922 sh
Andrews Ronald Asbury — Director
- Exercised922Common Stock→ 922 held
- Exercised922Restricted Stock Units→ 2,764 held
- +2,985 sh
Sims Andrew John Hugh MacIntyre — Chief Financial Officer
- Exercised1,533Common Stock→ 8,489 held
- Exercised1,165Common Stock→ 9,654 held
- Exercised287Common Stock→ 9,941 held
- Exercised1,533Restricted Stock Units→ 28,522 held
- Exercised1,165Restricted Stock Units→ 27,357 held
- Exercised287Restricted Stock Units→ 27,070 held
- +922 sh
Hawkins Richard J — Director
- Exercised922Common Stock→ 1,529 held
- Exercised922Restricted Stock Units→ 2,764 held
- +922 sh
Guse Kyle — Director
- Exercised922Common Stock→ 922 held
- Exercised922Restricted Stock Units→ 2,764 held
- +922 sh
van Es-Johansson An — Director
- Exercised922Common Stock→ 922 held
- Exercised922Restricted Stock Units→ 2,764 held
- +16,439 sh
Hedrick Marc H — Chief Executive Officer · Director
- Exercised6,387Common Stock→ 34,431 held
- Exercised8,066Common Stock→ 42,497 held
- Exercised1,986Common Stock→ 44,483 held
- Exercised6,387Restricted Stock Units→ 163,650 held
- Exercised8,066Restricted Stock Units→ 155,584 held
- Exercised1,986Restricted Stock Units→ 153,598 held
- +922 sh
Clowes Howard — Director
- Exercised922Common Stock→ 1,981 held
- Exercised922Restricted Stock Units→ 2,764 held
Insiders on this tape
- Andrews Ronald AsburyDirector
- Sims Andrew John Hugh MacIntyreChief Financial Officer
- Hawkins Richard JDirector
- Guse KyleDirector
- van Es-Johansson AnDirector
- Hedrick Marc HChief Executive Officer · Director
- Clowes HowardDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.